Dr. Aleksandra Fetyukhina, MD, Author at Swiss Medica

Dr. Aleksandra Fetyukhina, MD

General practitioner, intensive care specialist in cell therapy and regenerative medicine. Medical advisor, Swiss Medica doctor.

Follow author:
  • facebook
  • twitter
  • m

Publications

Diseases That We Treat With Stem Cells

Disease introduction Stem cell treatment for Multiple Sclerosis Multiple sclerosis…

  • Dr. Aleksandra Fetyukhina, MD
  • 10 Jun 2021
  • 4 min read
How Pneumonia Develops in Patients with Coronavirus. What is the Difference between Bacterial and Viral Pneumonia

The death toll from COVID-2019 caused by the new SARS-CoV-2…

  • Dr. Aleksandra Fetyukhina, MD
  • 19 May 2021
  • 13 min read
Potential of Mesenchymal stem cells (MSC) in Rehabilitation after Coronavirus COVID-19 and Treatment of its Complications such as Pulmonary Fibrosis

With the increased number of people who have contracted coronavirus…

  • Dr. Aleksandra Fetyukhina, MD
  • 19 May 2021
  • 6 min read
Swiss Medica Review

Before and after MS treatment documented by UK television Meet…

  • Dr. Aleksandra Fetyukhina, MD
  • 19 May 2021
  • 2 min read
Neurometabolic Protocol

Long-term abuse of drugs or alcohol tends to be very…

  • Dr. Aleksandra Fetyukhina, MD
  • 23 Apr 2021
  • 1 min read
Dry Needling – Myofascial Trigger Point Dry Needling

Pain, as a reflex, so does pain in autonomous disorders…

  • Dr. Aleksandra Fetyukhina, MD
  • 23 Apr 2021
  • 3 min read
Swiss Medica Participated in Neuro Rehabilitation Conference March 2015
  • Dr. Aleksandra Fetyukhina, MD
  • 18 Apr 2021
  • <1 min read
Safe and Deep Detoxification

The ambulant rehabilitation treatment consists of an infusion therapy with…

  • Dr. Aleksandra Fetyukhina, MD
  • 18 Apr 2021
  • 1 min read
Spark Wave Treatment Procedure

It is clinically tested and proven in various studies by…

  • Dr. Aleksandra Fetyukhina, MD
  • 18 Apr 2021
  • 3 min read

We use cookies on our site to ensure that we give you the best browsing experience. By continuing to browse the site, you agree to this use. For more information on how we use cookies, see our Cookie Policy and Privacy Policy.

Got it